
You already know this. You know the supratrochlear artery sits 3.34mm deep at the glabella, with a standard deviation of 0.6mm. You know the corrugator supercilii is only 2-3mm thick. You know that eyelid skin — the thinnest on the body — measures 0.3 to 0.5mm, with no subcutaneous fat beneath it.
What you may not have considered is what your syringe is doing while you work at those depths.
Upper-face aesthetic injection has a 16% total complication rate (meta-analysis). That number isn’t about bad technique. It’s about anatomy that doesn’t forgive small errors — delivered through instruments that weren’t designed for the precision the anatomy demands.
These aren’t rare anatomy. This is every patient, every treatment day.
A standard thumb-plunger syringe asks you to push forward on the plunger while holding the barrel steady. The biomechanics work against you: the force vector that moves the plunger also moves the needle. Every injection involves some amount of unintended forward-and-back needle movement at the tip.
In anatomy where 1-2mm separates a correct plane from a complication, that movement matters.
The Precision Syringe replaces the thumb-plunger mechanism with a finger-pull trigger. The force that delivers product is directed rearward — away from the needle tip, not toward it.
In a peer-reviewed study (DeLuna et al., Clinical Ophthalmology, 2019), the Precision Syringe demonstrated:
• 20.9% better needle stability vs. standard thumb-plunger syringe (p=0.04)
• 0.97mm reduction in forward-retraction needle movement
That fraction of a millimeter is the same order of magnitude as the clinical margins described above. We have not studied whether this improvement in needle stability changes complication rates. What the data show is that the instrument moves less while you work.
MOHS depends on precise tissue architecture. The entire method — excise, map, section, read margins, re-excise — assumes that what the surgeon removes corresponds accurately to what the pathologist sees on the slide.
Local anesthetic injection is the first thing that happens to the tissue. If injection technique distorts the tissue plane, every downstream step inherits that distortion.
Tissue distortion corrupts margin assessment.Imprecise injection — too much volume in too small a space, or delivery at the wrong depth — swells and deforms the tissue before the first cut. The surgeon maps a margin on distorted anatomy. The pathologist reads a specimen that shrank approximately 20% at excision. A margin that reads “clear by 1mm” on the slide may be positive in vivo.
Eyelid MOHS is unforgiving. Eyelid skin is 0.3-0.5mm thick with no subcutaneous fat. There is almost no buffer between the injection plane and the structures beneath. Precise depth control during anesthetic delivery isn’t a preference — it’s a requirement of the anatomy.
The facial danger zones are measured in millimeters.The facial artery at the nasal ala averages 3.13mm deep but can sit as superficial as approximately 1mm, with a lumen of 1.32mm. In the temporal danger zone, MOHS cases carry a 4.5% rate of temporal nerve palsy. Forty percent of those cases don’t resolve.
The workforce gap is real. Seventy-four percent of dermatology residents plan to offer cosmetic injection services. Only 36% feel adequately trained. The syringe they learn on will shape the habits they carry into independent practice.
MOHS surgeons inject local anesthetic dozens of times per day, often in the most anatomically complex regions of the face. The injection isn’t the procedure — it’s the setup for the procedure. But a syringe that introduces even small amounts of unintended needle movement can distort tissue, complicate margin reads, and put neurovascular structures at risk.
Standard thumb-plunger syringes direct force toward the needle tip. In periorbital skin that’s a third of a millimeter thick, or next to an artery that may be 1mm from the surface, that biomechanical reality deserves scrutiny.
The same peer-reviewed data apply here. DeLuna et al. (Clinical Ophthalmology, 2019 — senior author Dr. Donny Suh, Precision Syringe CMO) measured:
• 20.9% better needle stability vs. standard thumb-plunger syringe (p=0.04)
• 0.97mm reduction in forward-retraction needle movement
For MOHS, this means less unintended needle movement during anesthetic delivery — in tissue where distortion directly affects margin accuracy and where neurovascular anatomy leaves no room for instrument-induced error.
The Precision Syringe is compatible with standard Luer-lock needles and accepts the same cartridges and syringes you already use. It doesn’t require a new workflow — it changes the biomechanics of the one you have.
DeLuna D, Netzel A, Dietze J, Begley BA, Ndulue JK, Suh DW. “A comparison in precision and accuracy of the conventional syringe to the Suh precision syringe.” Clinical Ophthalmology, 2019;13:1833–1839.
The study measured needle stability — not clinical outcomes. We cite the published anatomical literature above to illustrate why needle stability matters in these specialties. We have not conducted studies on complication rates.
© 2026 Precision Syringe, Inc. All rights reserved.
Patents through 2040+ | 510(k) filed February 2026 DeLuna D, Suh DW, et al. “Comparison of modified syringe versus standard syringe use in a simulated intravitreal injection model.” Clinical Ophthalmology, 2019.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.